MEN’S ROGAINE (minoxidil) Johnson and johnson Patent: 6,946,120 Expiration: Apr 20, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations for…
Annual Drug Patent Expirations for PROAIR+RESPICLICK Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…
The post Patent delisted for Teva Branded drug PROAIR RESPICLICK …
By Joshua Mansour, M.D. Patients should have as much access to information as possible. The more they know, the more informed decision about their health and life that can be made. However, faulty headlines about new therapies are infiltrating news outlets left and right recently. Many times, this information can be misleading, and it is […]
ASTAGRAF XL (tacrolimus) Astellas Patent: 6,440,458 Expiration: Mar 25, 2019 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug Paten…
By Joshua Mansour, M.D. The head of the National Cancer Institute, Dr. Norman “Ned” Sharpless, will be temporarily appointed as acting commissioner of the Food and Drug administration amid the news of Dr. Scott Gottlieb stepping down for personal reasons. Dr. Sharpless oversees billions in grants for research and federal funding at his current position. Time will tell if […]
By Eddie Fatakhov, M.D. Advancements in technology are dramatically changing the world of medicine as we know it, and medical professionals worldwide are utilizing this rapidly evolving landscape to achieve and innovate the way we stay healthy. One vein of medicine that is really maximizing the potential of these advancements, while changing the face of […]
Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this compound. Drug patent…
The post New tentative approval for Watson Labs drug dienoge…
Recent successful drug launches indicate a trend toward more specialized, high-priced drugs that treat less-common medical conditions.
The post Conclusions We Can Draw from Recent Successful Drug Launches appeared first on DrugPatentWatch – Make Better…
Businessman and investor Mark Cuban is probably best known as the owner of the Dallas Mavericks and as an investor on the reality television series Shark Tank. His business and…
The post Mark Cuban Unexpected Leader in Orphan Drug Development Reform ap…
The average time to market for a new drug is around 12 years, at a cost averaging $2.6 billion, according to 2014 research by Tufts University. And there’s no indication that…
The post How AI Is Already Changing Drug Development appeared first on DrugP…